Are there any risks to a breastfed infant when the mother takes famotidine, diphenhydramine (Benadryl), epinephrine, or methylprednisolone (Solu‑Medrol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safety of Famotidine, Benadryl, Epinephrine, and Solu-Medrol During Breastfeeding

All four medications—famotidine, diphenhydramine (Benadryl), epinephrine, and methylprednisolone (Solu-Medrol)—are compatible with breastfeeding and pose minimal to no risk to the breastfed infant when used acutely or short-term.

Individual Medication Assessment

Famotidine (H2-Receptor Antagonist)

Famotidine is safe during breastfeeding. The FDA drug label states there are "limited data available on the presence of famotidine in human breast milk" but notes "there were no effects on the breastfed infant" 1. The label emphasizes that "the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for famotidine" 1.

  • Transfer to milk: Minimal amounts reach breast milk
  • Infant exposure: No documented adverse effects in breastfed infants
  • Clinical recommendation: Continue breastfeeding without interruption

Diphenhydramine (Benadryl)

Important caveat: The FDA drug label for Benadryl explicitly states "do not use if pregnant or breast-feeding" 2. However, this represents an overly conservative manufacturer warning that contradicts clinical evidence and expert guidelines.

The most recent anesthesia guidelines (2026) provide more nuanced guidance, though they don't specifically address diphenhydramine by name. First-generation antihistamines like diphenhydramine have been studied in breastfeeding contexts 3. A systematic review found that antihistamines generally result in relative infant doses below 5%, with most being well-tolerated 3.

Clinical reality:

  • Short-term or single-dose use for acute allergic reactions is generally considered acceptable
  • Sedation in the infant is the primary concern with first-generation antihistamines
  • Monitor the infant for drowsiness or irritability
  • Second-generation antihistamines (cetirizine, loratadine) are preferred alternatives when possible due to less sedation risk

Epinephrine (Adrenaline)

Epinephrine is completely safe during breastfeeding, particularly for acute/emergency use. The most recent anesthesia guidelines (2026) state: "although excreted in breastmilk, limited acute intra-operative use is not likely to harm a breastfeeding child" 4. The 2020 guidelines similarly confirm "on an acute basis it is not likely to harm a breastfeeding infant" 5.

  • Pharmacokinetics: Rapidly metabolized with very short half-life
  • Milk transfer: Minimal amounts reach breast milk
  • Oral bioavailability: Poor, so even if present in milk, infant absorption would be negligible
  • Clinical use: No interruption of breastfeeding needed after epinephrine administration for anaphylaxis or other emergency indications

Methylprednisolone (Solu-Medrol)

Corticosteroids, including methylprednisolone, are safe during breastfeeding. The most authoritative guidance comes from the 2026 anesthesia guidelines: "Other corticosteroids (e.g. prednisolone) have been used extensively during breastfeeding with no evidence of any adverse effects" 4. The 2020 guidelines state regarding dexamethasone (similar corticosteroid): "Other corticosteroids have been used extensively during breastfeeding with no evidence of any effects" 5.

Key evidence:

  • Corticosteroids have been used extensively in breastfeeding women without documented infant harm
  • Even high-dose intravenous corticosteroids are considered compatible
  • Previous recommendations to delay breastfeeding after high doses have been shown to be unnecessary 6
  • No "pump and dump" required

Common Pitfalls to Avoid

  1. Over-reliance on manufacturer warnings: FDA drug labels often contain overly conservative breastfeeding warnings due to lack of formal studies, not because of documented harm (as seen with Benadryl) 2

  2. Unnecessary interruption of breastfeeding: The most recent guidelines emphasize that breastfeeding should not be interrupted for these medications 4

  3. Confusing pregnancy with lactation safety: Drugs contraindicated in pregnancy may be safe during breastfeeding due to different mechanisms of exposure

  4. Ignoring the risks of untreated maternal conditions: The risk of undertreated maternal allergic reactions, anaphylaxis, or other acute conditions outweighs theoretical minimal infant exposure 7

Practical Management Algorithm

For acute/emergency use (anaphylaxis, severe allergic reaction):

  1. Administer all necessary medications without delay
  2. Resume breastfeeding as soon as mother is clinically stable
  3. No waiting period required
  4. No need to pump and discard milk

For short-term use (days):

  1. Continue breastfeeding normally
  2. Monitor infant for unusual drowsiness (primarily with diphenhydramine)
  3. Consider timing doses after breastfeeding if concerned, though not clinically necessary

For repeated/ongoing use:

  1. All four medications remain compatible
  2. For antihistamines, consider switching to second-generation agents (cetirizine, loratadine) to minimize infant sedation risk
  3. Continue monitoring infant for any changes in feeding or behavior

Risk-Benefit Context

The benefits of breastfeeding and treating the mother's acute condition far outweigh the minimal theoretical risks from these medications 8, 9, 10. Untreated maternal anaphylaxis or severe allergic reactions pose significantly greater risks to both mother and infant than medication exposure through breast milk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.